Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer

• Status: Completed
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine wether a complementary therapy consisting of a combined medication of selenium, milk thistle, goldenrod and bromelain and a consultation concerning nutrition and physical activity can reduce side effects of a chemotherapy in breast cancer patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Heidelberg University
• Collaborators: Cefak KG, Kempten; H. W. & J. Hector-Stiftung, Weinheim; Hector-Stiftung; Schwabe-Wenex International Ltd; Ursapharm, Saarbrücken

Criteria

Inclusion Criteria:

• Indication for chemotherapy for breast cancer for at least 3 cycles

Exclusion Criteria:

• Prior chemotherapy within 12 months

• use of herbal or nutritional supplements or other complementary or alternative medications ≥ 7 days prior to start of chemotherapy and during the trial

• allergy to study medication

• Selenium intoxication

• Current use of cumarins or other medication influencing the coagulation system

• Edema in case of impaired cardial or renal function

• Other severe medical condition

• Psychiatric or central neurological disorders

• Regular fluid intake < 2000 ml per day